Family structure size could affect breast cancer risk prediction accuracy for BRCA gene testingJune 20, 2007Researchers have found that the probability of the breast cancer gene mutation BRCA among women with a history of breast cancer is greater when the number of older, female relatives in the family is smaller, according to a study in the June 20 issue of JAMA. This finding may challenge the accuracy of some breast cancer prediction models, which may not take family structure into account. "Germline BRCA1 or BRCA2 gene mutations significantly increase a woman's risk of breast cancer (50 percent - 85 percent) and ovarian cancer (16 percent - 50 percent)," the authors write. "Documented efficacy of screening and risk reduction interventions provides evidence for individualized risk management advice, making genetic cancer risk assessment (GCRA) a component of medically necessary care. Identifying appropriate candidates for GCRA is challenging." Jeffrey N. Weitzel, M.D., of the City of Hope, Duarte, Calif., and colleagues conducted a study to determine if genetic risk models underestimate the BRCA gene mutation prevalence for "single-case indicators," that is, women with a limited family structure (less than two females who lived to age 45 or older in each lineage) who have early onset breast cancer and no family history of breast or ovarian cancers. "If true, a more accurate estimation of BRCA gene mutation probability may be needed for these women," the researchers write.
The study included 1,543 women seen at U.S. high-risk clinics for genetic cancer risk assessment and BRCA gene testing, who were enrolled in the study between April 1997 and February 2007. Three hundred six of these women had breast cancer before age 50 years and no first- or second-degree relatives with breast or ovarian cancers. Family structure was limited in 153 cases (50 percent). BRCA gene mutations were detected in 13.7 percent of participants with limited vs. 5.2 percent with adequate family structure. Participants with a limited family structure had an increased likelihood of being carriers of a BRCA gene mutation than those with adequate family structure. "Although statistically intuitive, limited family structure is akin to the problem of 'missing values' and is a limitation of all common mutation probability models. Consequently, absent better models, cancer risk assessment practices and genetic testing guidelines need to be more inclusive of single cases of breast cancer when there is limited family structure," the authors write. "The fact that commonly used models for estimating BRCA gene mutation probability were insensitive to family structure as a predictive factor is a cautionary note for community practitioners." "Given the significant effect of family structure, illustrated by limited accuracy of probability models for single cases of breast cancer, and the commonality of the missing-data problem, the databases of currently available probability models should be reanalyzed and limited family history recoded as a separate variable." JAMA and Archives Journals | |||||||||||||||||||||
|
Related Breast Cancer Current Events and Breast Cancer News Articles Genetic Engineering & Biotechnology News reports on growing role of molecular diagnostics Novel platform technologies and key advances in genomics are rapidly driving the development of molecular diagnostics, reports Genetic Engineering and Biotechnology News (GEN). Study looks at psychological impact of gene test for breast cancer Personal beliefs about inconclusive DNA testing for hereditary breast cancer are associated with cancer-related worry, and such beliefs are an especially strong predictor of whether women had been able to leave the period of DNA-testing behind. Second lumpectomy for breast cancer reduces survival rates A majority of women with breast cancer today are candidates for lumpectomy, allowing for conservation of most of their breast tissue. MRI spots DCIS in mice A new magnetic resonance imaging procedure can detect very early breast cancer in mice, including ductal carcinoma in situ (DCIS), a precursor to invasive cancer. Some of the tumors detected were less than 300 microns in diameter, the smallest cancers ever detected by MRI. Birth size is a marker of susceptibility to breast cancer later in life Birth size, and in particular birth length, correlates with subsequent risk of breast cancer in adulthood, according to a new study published in PLoS Medicine by researchers at the London School of Hygiene and Tropical Medicine. Social class dictates cancer risk Cervical and lung cancer are more common in poor people while rates of breast cancer and melanoma are higher in the wealthy. Cancer patients who receive neoadjuvant therapy followed by mastectomy may not need radiation Early-stage breast cancer patients who exhibit limited lymph node involvement may not require post-surgery radiation therapy (RT) when they receive neoadjuvant chemotherapy before a mastectomy, according to researchers from The University of Texas M. D. Anderson Cancer Center. New predictive tool can help determine treatment of breast cancer patients A new predictive measurement, called a PEPI score, could bring good news to many women diagnosed with early stage breast cancer - a low PEPI (preoperative endocrine prognostic index) score could show that they have little risk of relapse and can safely avoid chemotherapy after surgery. The dietary supplement genistein can undermine breast cancer treatment Women taking aromatase inhibitors to treat breast cancer or prevent its recurrence should think twice before also taking a soy-based dietary supplement, researchers report. Racial disparities decline for cancer in Missouri Cancer death rates in the United States are highest among African Americans, but a new report shows that in Missouri the disparity in cancer incidence and death between African Americans and whites is declining. More Breast Cancer Current Events and Breast Cancer News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||